AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Switch to ART with BIC/FTC/TAF achieves virological control in patients with low level viremiaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Residual HIV-1 RNA in 4d on/3d off (ANRS 170 QUATUOR) through W96View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Long-term Efficacy, Safety, and Durability of Ibalizumab-based Regimens in Subgroup of TMB- 202 ParticipantsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022K156N integrase substitution in combination with 3’PPT resistance mutations against dolutegravirView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Clonal Case Assessments for Participants Failing with Emergent Integrase Resistance in the DAWNING Second Line StudyView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Detection of mutations associated with antiretroviral drug resistance from HIV proviral DNA in patients with low-level viremiasView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Increasing protease inhibitor resistance mutations among HIV-infected children and adolescents with virologic failureView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Archived HIV-1 drug resistance is driven by NNRTI-mutations and associated with viral replication among adolescents in CameroonView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Update on transmitted drug resistance in newly diagnosed HIV patients during the period from 2019 to 2020View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Evolutionary dynamics of the recently identified HIV subtype a outbreak in Montenegro explored through advanced phylodynamic approachView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Quality of life of injecting drug users living with HIV in Minsk, BelarusView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2022Patterns of PrEP use among first- time users of oral HIV pre- exposure prophylaxis in the general population in EswatiniView Abstract
